Incyte Secures U.S. Food and Drug Administration Approval for Jakafi XR Incyte has announced a significant milestone with the approval of Jakafi XR™ (ruxolitinib) extended-release tablets by the U.S. Food and Drug Administration (FDA). This approval introduces a once-daily treatment…
Veradermics Prices Upsized Public Offering and Private Placement, Raising Over $400 Million Veradermics, Incorporated, a dermatologist-founded, late clinical-stage biopharmaceutical company focused on developing innovative treatments for pattern hair loss, has announced the pricing of an upsized public offering alongside a…
Genentech to Showcase Ophthalmology Data at ARVO 2026 Genentech is set to present a substantial body of new research highlighting the strength and breadth of its ophthalmology portfolio at the ARVO Annual Meeting 2026, taking place May 3–7 in Denver.…
The Hidden Risks of Self-Diagnosis A persistent headache that refuses to ease. A cough that lingers longer than expected. A new or unfamiliar symptom that raises quiet concern. In moments like these, many people instinctively turn to the internet for…
Strategic partnership launches CIO Leadership Exchange to empower IT leaders with AI, data, and digital transformation expertise across community health centers nationwide The National Association of Community Health Centers (NACHC) and NextGen Healthcare have announced a strategic partnership aimed at…
Dentrix Ascend Introduces MCP Layer, Ushering in a New Era of AI-Driven Dental Practice Management Henry Schein One, a global leader in dental software and technology solutions, has announced a major advancement in its cloud-based platform, Dentrix Ascend. The company…
Henry Schein Orthodontics Enhances Myofunctional Offerings with Froggymouth® Introduction Henry Schein Orthodontics (HSO), the orthodontics division of Henry Schein, Inc., has announced the availability of Froggymouth®, an innovative myofunctional device designed to assist in the management of orofacial dysfunctions. Manufactured…
Centene Corporation Reports Strong First Quarter 2026 Results, Raises Full-Year Outlook Centene Corporation announced solid financial and operational performance for the first quarter of 2026, highlighted by strong earnings, disciplined cost management, and continued progress in improving margins across its…
Survey points to rising concerns, cost barriers, and shifting help-seeking behaviors UnitedHealthcare has released findings from its fourth annual Young Adult & College Student Behavioral Health Report, offering a detailed look into the growing mental and behavioral health challenges faced…
United Therapeutics Announces Board Retirement of Prof. Raymond Dwek United Therapeutics Corporation has formally announced that Professor Raymond Dwek, C.B.E., F.R.S., will conclude his long-standing tenure as a member of the company’s Board of Directors at the 2026 Annual Meeting…
Rising Cyber Threats to Medical Devices Reshape Healthcare Priorities in 2026 A new wave of research highlights a growing and urgent challenge facing global healthcare systems: the increasing vulnerability of medical devices to cyberattacks and the direct consequences these threats…
BeOne Medicines Gains FDA Priority Review for TEVIMBRA in First-Line HER2+ Gastroesophageal Adenocarcinoma BeOne Medicines Ltd., a global oncology-focused biopharmaceutical company, has announced a major regulatory milestone in the development of a promising new treatment approach for patients with advanced…